Vasopressin in chronic kidney disease: an elephant in the room?
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The report by Perico et al that a dual arginine vasopressin (AVP) V2 and V1a receptor antagonist lowers blood pressure, proteinuria and glomerulosclerosis in 5/6 nephrectomized rats points to a potential therapeutic value of AVP receptor antagonists in the treatment of chronic kidney disease (CKD). A large body of evidence suggests that AVP likely contributes to CKD progression by its V2 and V1a-mediated effects on renal hemodynamics, blood pressure, and mesangial and/or epithelial cells. The relative contribution of V2 and V1a receptors to CKD progression and potential usefulness of V2 and V1a receptor antagonists for its treatment are not well defined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bankir, L. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00328-5 · Cited by 300
Bardoux, P., Martin, H., Ahloulay, M., Schmitt, F., Bouby, N., Trinh-Trang-Tan, M.-M., & Bankir, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10397 · Cited by 138
Bardoux, P. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/18.3.497 · Cited by 136
Vasopressin increases glomerular filtration rate in conscious rats through its antidiuretic action.
Bouby, N., Ahloulay, M., Nsegbe, E., Déchaux, M., Schmitt, F., & Bankir, L. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v76842 · Cited by 116
Cited by
Sontrop, J. M., Dixon, S. N., Garg, A. X., Buendia-Jimenez, I., Dohein, O., Huang, S.-H. S., & Clark, W. F. (2013) · American Journal of Nephrology · doi:10.1159/000350377 · Cited by 5,871
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
Torres, V. E., Chapman, A. B., Devuyst, O., Gansevoort, R. T., Perrone, R. D., Koch, G., Ouyang, J., McQuade, R. D., Blais, J. D., Czerwiec, F. S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1710030 · Cited by 639
Self-citationKumar, U., Wettersten, N., & Garimella, P. S. (2019) · Cardiology Clinics · doi:10.1016/j.ccl.2019.04.001 · Cited by 178
Clark, W. F., Sontrop, J. M., Huang, S.-H., Gallo, K., Moist, L., House, A. A., Weir, M. A., & Garg, A. X. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003666 · Cited by 38
Metadata
- Authors
- Torres, V. E.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 76
- Issue
- 9
- Pages
- 925-928
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2001771261
- Cited by
- 58
- References
- 4
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Vasopressin in chronic kidney disease: an elephant in the room? https://app.cochat.ai/papers/10.1038/ki.2009.325
- The paper
- Torres, V. E. (2009). Vasopressin in chronic kidney disease: an elephant in the room? Kidney International. https://doi.org/10.1038/ki.2009.325
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.